Can we safely use less blood for leukemia patients?
NCT ID NCT06710418
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving blood transfusions only when hemoglobin drops below 7 gm/dL (instead of 9 gm/dL) is safe and maintains quality of life in leukemia patients after chemotherapy or stem cell transplant. About 50 adults with certain blood cancers will be randomly assigned to one of two transfusion thresholds. The goal is to see if the lower threshold is feasible and doesn't cause more bleeding or worse quality of life, which could help conserve blood supplies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Packed red blood cell transfusion
- What this could lead to
- If successful, this could show that using a lower hemoglobin threshold for transfusions is safe and effective, helping conserve blood supplies and reduce side effects.
- What could go wrong
- This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The restrictive threshold might not maintain quality of life as well as the liberal one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fred Hutch/University of Washington Cancer Consortium
RECRUITINGSeattle, Washington, 98109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Could muscle loss predict blood cancer outcomes?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?